chr13-23334325-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4BP6
The NM_014363.6(SACS):c.9551G>A(p.Arg3184His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000046 in 1,610,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3184C) has been classified as Likely benign.
Frequency
Consequence
NM_014363.6 missense
Scores
Clinical Significance
Conservation
Publications
- Charlevoix-Saguenay spastic ataxiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SACS | NM_014363.6 | MANE Select | c.9551G>A | p.Arg3184His | missense | Exon 10 of 10 | NP_055178.3 | ||
| SACS | NM_001437336.1 | c.9578G>A | p.Arg3193His | missense | Exon 11 of 11 | NP_001424265.1 | |||
| SACS | NM_001278055.2 | c.9110G>A | p.Arg3037His | missense | Exon 8 of 8 | NP_001264984.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SACS | ENST00000382292.9 | TSL:5 MANE Select | c.9551G>A | p.Arg3184His | missense | Exon 10 of 10 | ENSP00000371729.3 | ||
| SACS | ENST00000455470.6 | TSL:1 | c.2432-4841G>A | intron | N/A | ENSP00000406565.2 | |||
| SACS | ENST00000682944.1 | c.9578G>A | p.Arg3193His | missense | Exon 11 of 11 | ENSP00000507173.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152022Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000804 AC: 20AN: 248788 AF XY: 0.0000817 show subpopulations
GnomAD4 exome AF: 0.0000453 AC: 66AN: 1458182Hom.: 0 Cov.: 37 AF XY: 0.0000497 AC XY: 36AN XY: 724990 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.9551G>A (p.R3184H) alteration is located in exon 10 (coding exon 9) of the SACS gene. This alteration results from a G to A substitution at nucleotide position 9551, causing the arginine (R) at amino acid position 3184 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Hereditary spastic paraplegia Uncertain:1
Charlevoix-Saguenay spastic ataxia Uncertain:1
Spastic paraplegia Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at